UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Plasma metabolites, metabolic risk score and colorectal cancer risk: a prospective cohort study

Deng, Y; Yang, M; Peng, P; Lin, Y; Lin, J; Huang, J; Wu, K; ... Hu, F; + view all (2025) Plasma metabolites, metabolic risk score and colorectal cancer risk: a prospective cohort study. European Journal of Epidemiology 10.1007/s10654-025-01284-z.

[thumbnail of manuscript0618-EJE Fulan Hu.pdf] Text
manuscript0618-EJE Fulan Hu.pdf - Accepted Version
Access restricted to UCL open access staff until 5 September 2026.

Download (417kB)

Abstract

The associations of colorectal cancer (CRC) risk with metabolites, lifestyle factors and their joint effects have not been fully elucidated. Therefore, we conducted a prospective cohort study to estimate the associations of CRC risk with metabolites, metabolic risk score (MRS) and its joint associations with lifestyle factors. This study included 82,514 participants with plasma metabolites data in the UK Biobank. LASSO-COX and Random Forest was used to select metabolites. Cox regression was utilized to construct MRS and estimate the associations of CRC risk with metabolites, MRS and its joint associations with lifestyle factors. Single-cell RNA sequencing data were analyzed to identify metabolism-related genes and metabolic pathways during CRC progression. During a median follow-up of 13.28 years, 1151 incident CRC cases were identified. MRS, constructed using 6 metabolites, was significantly associated with increased CRC risk (HR = 1.39, 95% CI 1.22–1.56 for high vs. low MRS), with the strongest association for proximal colon cancer (HR = 1.51, 95% CI 1.24–1.84), followed by distal colon cancer and rectal cancer (HR = 1.35, 95% CI 1.05–1.72; HR = 1.37, 95% CI 1.11–1.69). Joint associations were identified between MRS and lifestyle factors with CRC risk. Individuals with healthy sleep, never smoking, healthy diet, and healthy lifestyle but high MRS also exhibited elevated CRC risk. Linoleic acid, histidine and tyrosine metabolism pathways played important roles during normal intestinal mucosa to CRC progression. Pre-diagnostic metabolites and MRS were significantly associated with increased CRC risk, especially proximal colon cancer. Individuals should maintain normal metabolite levels and healthy lifestyles for CRC prevention.

Type: Article
Title: Plasma metabolites, metabolic risk score and colorectal cancer risk: a prospective cohort study
Location: Netherlands
DOI: 10.1007/s10654-025-01284-z
Publisher version: https://doi.org/10.1007/s10654-025-01284-z
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords: Colorectal cancer, Joint effects, Metabolic risk score, Metabolites, Single-cell sequencing
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Epidemiology and Health > Behavioural Science and Health
URI: https://discovery.ucl.ac.uk/id/eprint/10218860
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item